Respiratory in Biological Technology

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

... against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, ... of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as ... are currently the front-line treatments for respiratory tract infections such as CAP. As macrolide and ...

Cornerstone Therapeutics Announces Closing of Chiesi Transaction

... significant products primarily for the respiratory and related markets, today announced that it has ... the U.S. Food and Drug Administration ("FDA") for respiratory Distress Syndrome in premature infants, and $15.5 ... significant products primarily for the respiratory and related markets. The Company currently ...

Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies

... NVAX ) announced today final selection of a respiratory Syncytial Virus (RSV) vaccine candidate that will ... virus uses to infect and fuse with cells in the respiratory tract and cause disease. The new RSV-F ... immune responses to prevent infection of the respiratory tract and ...

Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments

... and commercializing products primarily for the respiratory and related markets. Cornerstone currently ... to underpromoted, patent-protected, branded respiratory or related pharmaceutical products, or late-stage ... specialty sales force which is focused on the respiratory and related markets; and maintain and strengthen ...

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

... prescription drug products for the treatment of respiratory diseases, respiratory-related allergies and ... As the U.S. leader in sales of nebulized respiratory medication, Dey puts patients first through its ... and operates a specialty business focused on respiratory and allergy therapies. For more information, ...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

... long history in developing therapies for treating respiratory diseases. This strategic action will allow us to ... Background on Schering-Plough and Novartis respiratory collaborations In October 2002, ... allergic rhinitis, sore throat, and upper respiratory infection. Additional important product ...

The Chiesi Group Lands in the United States

... synergies and new projects in the area of respiratory illnesses. The Chiesi Group has completed ... is the world's leading drug for treating respiratory distress syndrome in premature babies. The ... for some of the projects we are developing in the respiratory area." "This agreement means a major ...

Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again

... of measles, mumps, flu and other airborne respiratory illnesses in schools and hospitals since the ... of SARS. These illnesses, plus other respiratory infections such as the Flu (all types), are ... airborne diseases spread through contact with respiratory secretions from an infected person (a cough or ...

NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza

... in the field of clinical development of drugs for respiratory viral infections," said Ron Moss, M.D., NexBio's ... Canadian Academies Expert Panel on Influenza and respiratory Protection, and the Canadian National Advisory ... viral receptors on the cells of the human respiratory tract, thereby preventing influenza, including ...

Cornerstone Therapeutics to Present at BioCentury's 2009 Future Leaders in the Biotech Industry Conference

... significant products primarily for the respiratory market, today announced that Craig A. Collard, ... significant products primarily for the respiratory market. The Company currently promotes multiple ... to underpromoted, patent-protected, branded respiratory pharmaceutical products, or late-stage product ...

Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results

... significant products primarily for the respiratory market, today reported financial results for the ... expanding our sales and marketing team within the respiratory market to further drive our current market ... and commercializing products primarily for the respiratory and related markets. The Company currently ...

Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System

... /PRNewswire/ -- Offering the latest in modular respiratory protection, Avon Protection Systems - a ... the design and manufacturing of industry-leading respiratory protection products, Avon Protection is the sole ... expertise. Avon supplies a range of advanced CBRN respiratory protection solutions through Avon Protection ...

EPA Awards Lovelace Respiratory Research Institute $500,000 for Air Quality Research

... Research Institute, a subsidiary of Lovelace respiratory Research Institute, LRRI. The award is to ... one of the more than 100 scientists working on respiratory disease research at LRRI. Dr. Campen says, "We ... for a long time that air pollution contributes to respiratory disease. This generous grant from the EPA ...

Enobia Completes Target Enrollment in Clinical Trial for Infantile Hypophosphatasia

... hypophosphatasia infants with severe rickets and respiratory compromise. Six severely affected infants from ... with profound skeletal hypomineralization and respiratory compromise often causing death, to a more slowly ... of life. These can include failure to thrive, respiratory failure, fractures, and seizures. Radiographic ...

Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer

... products for the treatment of widely prevalent respiratory diseases, announced today the appointment of ... of its portfolio of novel products to treat respiratory diseases and we are confident that Perry, with ... high quality therapies to patients with serious respiratory diseases," stated Mr. Karsen. "Pearl's line of ...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

... than pneumonia (e.g., bronchitis and viral lower respiratory tract infections) in patients receiving SYMBICORT ... bronchitis, sinusitis and viral upper respiratory tract infection.(2) "Through these pivotal ... SYMBICORT is a combination of two proven respiratory medications - budesonide, an inhaled ...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

... ) announced results from a preclinical study of a respiratory Syncytial Virus ("RSV") vaccine candidate ... utilizes the F protein to fuse with cells in the respiratory tract and cause illness. Novavax's RSV-F VLPs ... are important for preventing infection and lower respiratory illness, were highest in the "VLP plus adjuvant" ...

Pearl Therapeutics Secures $8 Million in Debt Financing

... technology that will treat and prevent chronic respiratory diseases," said J. Alden Philbrick, President and ... toward achieving a leadership role in the respiratory space." "Pearl is developing cutting edge therapeutics to address some of the most serious respiratory diseases," said Mercy Forde of Silicon Valley ...

Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)

... explanation for SUDEP, evidence suggests a respiratory failure during seizure. Research has revealed ... but also prevent SUDEP that would result from respiratory dysfunction of failure", said Mr. Kameli. He ... analysis of these deaths suggests that abnormal respiratory patterns during seizure may have led to an ...

Naglazyme Approved by Brazil's National Health Surveillance Agency

... were headache, fever, arthralgia, vomiting, upper respiratory infections, abdominal pain, diarrhea, ear pain, ... edema, hypotension, dyspnea, bronchospasm, respiratory distress, apnea, and urticaria. The most common ... patients who present with an acute febrile or respiratory illness. Additional information can be found at ...

Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease

... specific tests that more accurately diagnose respiratory infectious diseases. This technology, called ... chief executive officer of LGMC. "Complex respiratory infections are a major challenge faced by ... be able to quickly and more accurately diagnose a respiratory infection as well as co-infections, which may go ...

NexBio to Present at 2009 Biotech Showcase

... candidate for the prophylaxis and treatment of respiratory infections by all variations of influenza virus, ... seasonal influenza-like illness due to multiple respiratory viruses, including parainfluenza virus, which may cause a serious respiratory illness similar to influenza and for which there ...

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

... severe dysphagia (difficulty swallowing) and respiratory compromise from typical doses of BOTOX(R) and ... medical attention if swallowing, speech, or respiratory disorders arise. Side Effects ... include difficulty swallowing (19%), upper respiratory infection (12%), neck pain (11%), and headache ...

AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in 'Improving Patient Outcomes and Reducing Costs' in Post-Acute Care Facilities

... Excellence at the 54th Annual International respiratory Congress in Anaheim IRVINE, Calif., Dec. ... Ventilation Care at the American Association of respiratory Care (AARC) 54th Annual International Congress in ... RRT and Manager of Business Development for Linde respiratory Support Services (RSS), a leader in ...

Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury

... of the research will be conducted by the Lovelace respiratory Research Institute (LRRI), a not-for-profit ... visit www.parion.com . About Lovelace respiratory Research Institute Lovelace respiratory Research Institute is a not-for-profit ...

NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate

... announced results from a preclinical study of a respiratory Syncytial Virus ("RSV") vaccine candidate. ... to enhance shareholder value." About respiratory Syncytial Virus RSV is the most commonly identified cause of lower respiratory tract infection in infants and young children ...

Advanced Life Sciences Announces Third Quarter 2008 Financial Results

... in the therapeutic areas of infection, cancer and respiratory diseases, today announced its financial results ... of death in the United States. CAP and other respiratory tract infections are caused by pathogens such ... in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, ...

Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA

... bacteria isolated from community-acquired respiratory tract infections (CARTI), including oxacillin- ... active against more than 500 community-acquired respiratory tract clinical isolates, ... (2008) bacteria isolated from community-acquired respiratory tract infections (CARTI), ...

Advanced Life Sciences Completes Debt Transaction

... in the therapeutic areas of infection, cancer and respiratory diseases, today announced that it closed a debt ... in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, ... once-a-day oral antibiotic for the treatment of respiratory tract infections including community acquired ...

PARI Respiratory to Present New Study Comparing Nebulizers Delivering Budesonide at CHEST 2008

... director of clinical development for PARI respiratory Equipment, Inc. The study compares the LC ... LC PLUS Reusable Nebulizer (PARI respiratory Equipment), and Sidestream Plus reusable ... College of Chest Physicians. About PARI respiratory Equipment, Inc. PARI is a leading worldwide ...

Advanced Life Sciences Announces Presentations at Fall Scientific and Investor Conferences and Third Quarter 2008 Earnings Conference Call

... and an oral presentation pertaining to its lead respiratory antibiotic cethromycin. The Company will also sponsor a "Meet the Experts" series focused on respiratory tract pathogens and bacterial resistance led by ... in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, ...

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease

... growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants. "As we gain ... RSV infections, the leading cause of lower respiratory tract infections in infants in the United States. ...

Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents

... is the lack of ventilators for people requiring respiratory support. Disaster specialists and health care ... -- mechanical ventilation for people with respiratory failure might have to be provided outside acute ... Inc. (Nasdaq: AHPI ) manufactures a variety of respiratory products used in the healthcare industry in a ...

Pharmaxis Research Programs Highlighted at European Respiratory Society Congress

... researchers will present 12 abstracts from its respiratory disease program at the 2008 European respiratory Society Congress (ERS) being held in Berlin from ... The ERS brings together many of the world's top respiratory researchers and clinicians to hear ...

Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)

... Food and Drug Administration for the treatment of respiratory distress syndrome (RDS) in newborns. "We ... neonatal intensive care unit (NICU) nurses, respiratory therapists, hospital pharmacists, ... for application across the continuum of respiratory diseases, initially focusing on RDS in premature ...

Advanced Life Sciences Announces Second Quarter 2008 Financial Results

... in the therapeutic areas of infection, cancer and respiratory diseases, today announced its financial results ... of death in the United States. CAP and other respiratory tract infections are caused by pathogens such ... in late-stage development for the treatment of respiratory tract infections including CAP. For more ...

Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast

... in the therapeutic areas of infection, cancer and respiratory diseases today announced that it will host a ... in the therapeutic areas of infection, cancer and respiratory diseases. The company's lead candidate, ... in late-stage development for the treatment of respiratory tract infections. For more information, please ...

Advanced Life Sciences Added to Russell Microcap Index

... in the therapeutic areas of infection, cancer and respiratory diseases, today announced that it was added to ... in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, ... in late-stage development for the treatment of respiratory tract infections including CAP. For more ...

Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index

... in the therapeutic areas of infection, cancer and respiratory diseases, today announced that it was selected as ... in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, ... in late-stage development for the treatment of respiratory tract infections including CAP. For more ...

Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation

... options for those suffering from serious respiratory illnesses such as COPD." For those attending ... As the U.S. leader in sales of nebulized respiratory medication, Dey, L.P. puts patients first through ... delivered by nebulization to COPD patients. respiratory Medicine, 2008, 102, 189-197 Media ...